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Summary
Homozygosity for either of the lymphoproliferation (lpr) or generalized lymphoproliferative disease
(g1d) mutations o£ mice causes the development of systemic lupus erythematosus-like autoimmune
syndromes that are characterized by severe lymphadenopathy and highly elevated serum
immunoglobulin levels. Although the mutations are nonallelic, analysis of homozygous lpr/lpr
and gidlgld mice on the same strain background has indicated that the pathology and severity
of the autoimmune syndromes induced by these mutations are indistinguishable. To explain this,
it has previously been suggested that lpr and gld may represent mutations in molecules involved
in sequential steps of an intracellular metabolic pathway of T cells. We have now investigated
the behavior ofboth lpr andgldin a variety ofbone marrow chimeras and have found that functional
differences between lpr and gld become apparent after bone marrow transfer. Transfer of lprllpr
bone marrow to irradiated congenic + /+ recipientscaused the development of a graft-vs.-host-like
lymphoid wasting syndrome, whereas transfer ofgld/gld bone marrow to + /+ recipients resulted
in development ofagld-like autoimmune syndrome. Additionally, gld/gld hosts behaved like + /+
hosts irrespective of the genotype of the donor bone marrow, whereas lpr/lpr hosts behaved unlike
+ /+ hosts when reconstituted with either lpr/lpr, gld/gld, or + /+ bone marrow. These are
the first clear differences between these two mutations yet described. Our studies indicate that
the molecule altered by theg1dmutation is expressed only by bone marrow-derived cells, whereas
the molecule altered by the lpr mutation is expressed by both bone marrow-derived cells and
by one or more peripheral radioresistant cell populations. To reconcile these differences with
the fact that homozygous lpr/lpr andgld/gld mice are indistinguishable, we suggest an alternative
model for the relationship between the lpr and gld mutations in which the two molecules affected
represent an interacting ligand-receptor pair expressed by different cells.
Homozygosity for the recessive mutation lymphoprolifer-
ation (lpr) causes an SLE-like autoimmune syndrome
in mice characterized by high serum Ig levels, development
of autoantibodies and proliferation of a CD4 - CD8 - T cell
population (1-4). This mutation first arose during deriva-
tion of the MRL/Mpj (MRL) strain and was subsequently
transferred by repeated backcrossing to a number of other
inbred strain backgrounds including C3H/Hej (C3H) . Al-
though the fundamental phenotype described abovedevelops
in lprllpr mice of all strains, there are differences in the severity
and associated pathology of the lpr-induced autoimmune syn-
drome in different strains (3). This suggests that "background"
genes can modify phenotypiccharacteristics of thelpr-induced
autoimmune syndrome.
Another recessive mutation, designated generalized lym-
phoproliferative disease (g1d) occurred in the C3H strain and
produces phenotypic features very similar to those induced
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by 1pr (3-7). It has been reported that the autoimmune syn-
dromes induced by these two genes differ significantly (8).
However, this conclusion was drawn by comparison of
homozygous lpr/lpr and gld/gld mice ofdifferent strain back-
grounds. When studied on the same strain background (e.g.,
C3Hgld/gld vs. C3H-lpr/1pr), no differences in longevity, de-
gree or rate oflymphoproliferation, serum Ig levels, anti-DNA
autoantibody levels, or phenotype ofthe abnormallyexpanded
T cell population have been found (Sidman et al., unpub-
lished data; see also references 7 and 9). Thus, it is likely that
the previously noted differences in the effects of these two
mutations were due to differences in modifying "background"
genes and not to differences between the lpr andgld mutations.
The gld mutation has been mapped to chromosome 1 (5),
while the location ofthe 1pr mutation has not yet been deter-
mined. However, it has been demonstrated that gld and lpr
are nonallelic (5). These two mutations therefore identify dis-
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dromes. In view of this, it has been suggested that lpr and
gld are mutations in sequential enzymes in an intracellular
metabolic pathway of T cells (6).
Bone marrow from homozygous lpr/1pr mice demonstrates
unusual behavior upon transfer to irradiated congenic + /+
recipients. Rather than recreating an lpr-like autoimmune syn-
drome in + /+ hosts, lpr/Ipr bone marrow induces a graft-
vs.-host (GVH)-like syndrome (10, 11) consisting ofan early
inflammatory response with transient splenomegaly and lymph-
adenopathy (12) followed by progressive lymphoid atrophy
(13). This GVH-like syndrome in lpr/1pr -> + /+ bone
marrow chimeras appears to be due to a functional defect
associated with the lpr mutation rather than to an antigenic
difference between congenic lpr/1pr and + /+ mice (12).
In the current report, we compare the behavior of cells
from homozygous gld/g1d and lpr/1prmice in a series ofbone
marrow transfer experiments. The results obtained suggest
that these two mutations are expressed by different cell com-
partments and thus argue against the previoushypothesis that
these mutations affect sequential steps of a single intracel-
lularmetabolic pathway. We therefore propose an alternative
model for the relationship between the Ipr and g1d mutations,
in which they affect an interacting pair of molecules.
Materials and Methods
Mice.
￿
All experiments described were performed using mice
of the C3H/Hej (C3H) genetic background. Essential observa-
tions (absence of early splenomegaly in gld/gld --> + /+ chimeras,
development of lymphadenopathy rather than lymphoid wasting
ingld/gld - + /+ chimeras, and development ofa lymphoid wasting
syndrome in Ipr/lpr-g1d/g1d chimeras) were confirmed using mice
of the C57BL/6J genetic background in order to verify that the
observed differences in the behavior of the lpr and gld mutations
were not due to strain-specific effects of background genes.
The lpr mutation aroseduring derivation oftheMRL/Mpj strain
and was subsequently transferred onto the OH background by
10 cycles of cross-intercross matings (1-3). The gld mutation. ini-
tially arose in the C3H strain (5). Donor and recipient mice in
all bone marrow transfer experiments were 4-11 wk of age at
transfer. Bone marrow chimeras are indicated as donor genotype
-" host genotype. Although lpr andgld represent mutations at sep-
arateloci, by convention, only altered loci are indicated in chimera
designations (e.g., gld/gld -+ Ipr/lpr is actually g1d/gld, + /+ --"
+ /+ , lpr/lpr).
Bone Marrow Transfer.
￿
Bone marrow cells were prepared by
flushing the femurs and tibias of donor mice with Earle's Balanced
Salt Solution (Gibco Laboratories, Grand.Island, NY) supplemented
with 2% FCS (Biofluids Inc., Rockville, MD) (EBSS/2% FCS).
Cellswere harvested by centrifugation at 200 g for 10 min at 4°C,
washed twice in EBSS/2% FCS under the same conditions, and
then resuspended in 0.9% NaCl to a concentration of 2 x 107
viable cells/ml. Recipient mice received 1,000 rad ofirradiation from
a 117CS source at a rate of 186-190 rad/min, and then received 5
x 106 donor marrow cells via the tail vein.
Necropsy ofMice.
￿
Upon necropsy, the spleen, as well as the left
and right axillary, brachial, and inguinal lymph nodes, were dis-
sected free of adjacent tissue and weighed. The term "lymph node
weight" used throughout Results refers to the combined weight
of these six lymph nodes.
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Determination ofImmunoglobulin Levels by ELISA.
￿
All Ig levels
were determined by means ofan ELISA method, as previouslyde-
scribed (14) .
Results
Differences between Bone Marrow Cellsfrom Ipr/Ipr
and gld/gld Mice
We have previously demonstrated that transfer of lpr/lpr
bone marrow to irradiated congenic + /+ recipients results
in an early phase of lymphadenopathy and splenomegaly that
begins at N3 wk, peaks at 5 wk, and declines by 9 wk post-
transfer (12). This phase ofsplenomegaly and lymphadenop-
athy is accompanied by a sharp rise in serum IgG1 and (to
a lesser extent) IgG2 levels, which also peak at ti5 wk and
return to normal by 9 wk post-transfer.
To determine whether the gld mutation causes the same
effects after marrow transfer as the Ipr mutation, we analyzed
C3H-+ /+ mice reconstituted with congenic C3H-+ /+ ,
-Ipr/Ipr, or -gld/gldbone marrow. Although transfer of lpr/lpr
bone marrow to + /+ recipientsresulted in significant spleno-
megalyby 40 d post-transfer, gld/gld --" + /+ chimeras demon-
strated no comparable increase in spleen weight at this time
(Table 1, groups 2a vs. 3a). This indicates a functional differ-
ence between pr/pr and gld/gld bone marrow.
We also- compared the effects of lpr/Ipr and gld/gld bone
marrow cells on serum Ig levels in congenic + /+ recipient
mice. Although lpr/lprbone marrow caused a significant in-
crease in serum IgG1 and IgG2b in congenic + /+ recipients
by 5 wk post-transfer (as expected from previous results [12]),
gld/gld bone marrow did not induce an early rise in IgG levels
(Table 2) . We have previously demonstrated that the early
increase in serum IgG1 levels also occurs in lpr/lpr --> lpr/lpr
chimeras and is thus a functional effect of the Ipr mutation
per se, rather than of the interaction of lpr/Ipr bone marrow
cellswith the + /+ host environment (12). The inability of
gld/gld bone marrow to induce the transient IgG response
therefore represents anther functional difference between the
lpr and g1d mutations.
Differences between the lpr/1pr and gld/gld
Host Environments
Recipients of Ipr/lpr Bone Marrow Cells.
￿
Although Ipr/Ipr
-~ lpr/1pr chimeras did not demonstrate significant early
splenomegaly (Table 1, group 2b vs. 1b), Ipr/lpr -" g1d/gld
chimeras did demonstrate this phenomenon (Table 1, group
2c vs. 1c). Histological analysis indicated that the splenomegaly
occurring in lpr/Ipr - gld/gld chimeras was due to the same
type of inflammatory response as was observed in lpr/lpr
+ /+ chimeras (not shown). This indicates that donor cells
of the lpr/lpr genotype recognize the gld/gld host environ-
ment as + /+-like rather than as lpr/lpr-like, and thus, that
the g1d/g1d and lpr/lpr host environments differ in some func-
tional parameter.
To further investigate this difference between the lpr/lpr
and g1d/gld host environments, we assessed the long-term de-
velopment ofchimeras constructed from all nine possible donorTable 1.
￿
Lymphoid Organ Weights in Chimeras S-6 wk after Transfer
Chimera
1. +/+ Donor
a. +/+ -" +/+
b. +/+ -Iprllpr
c. +/+ -+ gldlgld
2. Iprllpr Donor
a. lprllpr - +/+
b. lprllpr --> lprllpr
c. lprllpr - gldlgld
3. gldlgld Donor
a. gldlgld - + /+
b. gldlgld - lprllpr
c. gldlgld - gldlgld
Statistically significant ([t] p < 0.05; [t+] p 4 0.01 by Mann-Whitney analysis) increases in comparison with +/+ donor- same recipient group.
' Lymph node weight refers to the combined weights of the left and right axillary, brachial, and inguinal lymph nodes. Results are expressed to
three significant figures and indicated as mean ± SE.
- host combinations of the Iprllpr, gldlgld, and +/+ geno-
types. Sets of the nine groups of chimeras were necropsied
at 5 and 12 mo post-transfer and assessed for the degree of
lymph node and spleen enlargement or atrophy. As described
below, significant differences emerged in the behavior of all
marrow typesin thelprllpr vs. thegldlgldhost environments.
Confirming earlier studies (10-12), Iprllpr- +/+ chimeras
(Table 3, group 2a) developed a lymphoid wasting syndrome
characterized by decreasedspleen weights and atrophic lymph
nodes. Additionally, lpr/lpr-;gldlgldchimeras (Table 3, group
2c) developeda similarlymphoid wasting syndrome, consis-
tent with the occurrence of early splenomegaly in thesemice
(t) Statistically significant (p 4 0.05 by Mann-Whitney analysis) increases in comparison with +/+ -
' Results are expressed to two significant figures and indicated as mean ± SE (three mice per group).
t Total refers to the sum of the six Ig classes measured.
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(Table 1). However, the lprllpr - Iprllpr chimeras (Table 3,
group2b) developedlymphadenopathy and splenomegaly typ-
ical of homozygous lprllpr mice.
Analysis of Ig levels at 5 mo post-transfer supported these
findings. As shown in Table 4, Ig levels in Ipr/lpr - +/+
(group 2a) andlprllpr -,~gldlgld(group 2c)chimeras showed
little elevation, with several isotypes being significantly
depressed rather than increased. This was presumably because
of the development of the lymphoid wasting syndrome in
these mice. However, Ig levels in lprllpr -> lprllpr chimeras
(group 2b) were highly elevated.
In a separate experiment, we performed a kinetic analysis
+/+ group.
n Spleen weight Lymph node weight'
mg mg
6 93.7 ± 7.7 20.8 ± 1.9
7 109 ± 5 22.8 ± 2.0
8 103 ± 5 22.4 ± 1.1
7 153 ± 16t 27.4 ± 2.9t
7 112 ± 5 25.6 ± 2.3
8 164 ± 16tt 31.2 ± 3.2tt
7 83.6 ± 3.5 17.9 ± 0.8
7 91.1 ± 21 .3 25.7 ± 2.6
8 114 ± 8 23.9 ± 3.1
Table 2.
Isotype
Serum Ig Levels in Chimeras 5-6 wk after Transfer
+/+ - +/+ lpr/lpr - + / + gldlgld - + / +
Aglml icglmI ilglml
Igm 680 ± 40' 750 ± 90 640 ± 80
IgG1 240 ± 70 590 t lot 170 ± 10
IgG2a 190 t 60 410 t 90 190 ± 80
IgG2b 130 ± 20 300 t 60t 130 ± 20
IgG3 270 ± 80 900 t 540 270 ± 20
IgA 310 ± 50 500 t 130 380 ± 140
Totalt 1,800 ± 140 3,500 t 850t 1,800 ± 100Table 3.
￿
Lymphoid Organ Weights in Chimeras 5 and 12 mo after Transfer
Chimera
1. +/+ Donor
a. +/+ -y +/+
b. + / + -~ lprllpr
c. + / + -~ gld/gld
2. lprllpr Donor
a. lprllpr - + / +
b. lprllpr -" lpr/lpr
c. lprllpr - gld/gld
3. gld/gld Donor
a. gld/gld -" + / +
b . gld/gld - lprllpr
c. gld/gid -" gld/gid
Table 4.
￿
Serum Ig Levels in Chimeras 5 mo after Transfer
Chimera
1. + /+ Donor
a. +/+ -" +/+
b. + /+ -~ lprllpr
c. + / + -- gld/gid
2. lprllpr Donor
a. lprllpr -" + /+
b. lprllpr -> lprllpr
c. lprllpr - gld/gld
3. gld/gld Donor
a. gld/gld - + / +
b. gld/gld - Ipr/lpr
c. gld/gld - gld/gid
Spleen weight
￿
Lymph node weight
" All values areexpressed to three significant figures and are indicated as mean ± SE. The number of mice in each groupis indicated in parentheses.
Open arrows indicate statistically significant ([4] p < 0.05; [44] p 4 0.01 by Mann-Whitney analysis) increases (4) or decreases (4) in comparison
with same donor -+ + /+ recipient.
Closed arrows indicate statistically significant ([t] p 4 0.05; [tt] p < 0.01; [ttt] p 4 0.001 by Mann-Whitney analysis)
increases (t) or decreases (i) in comparison with +/+ donor - same recipient.
of a similar set of C3H chimeras, in which individual mice
were bled at intervals until 300 d post-transfer and serum
IgG2b levels were determined. As shown in Fig. 1, IgG2b
levels increased steadily in lprllpr -> lprllpr chimeras, but
Igm IgGl IgG2a
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' Results are expressed to two significant figures and indicated as mean ± SE (three to eight mice per group) . Total refers to the sum of the six
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showed no increase in lprllpr - + /+ or lprllpr -" gid/gld
chimeras.
These results indicate that lprllpr bone marrow behaves
differently in the lprllpr vs. the gld/gld (and + /+ ) host en-
Isotype
IgG2b IgG3 IgA Total
hg/ml
460 ± 40" 500 ± 30 980 ± 120 340 ± 60 260 ± 70 180 ± 20 2,700 ± 70
850 ± 280 410 ± 70 1,500 ± 590 370 ± 170 350 ± 90 110 ± 204 3,600 ± 900
530 ± 40 560 ± 110 1,300 ± 170 300 ± 60 250 ± 50 120 ± 10b 3,000 ± 330
530 ± 70 390 ± 804 1,900 ± 410 180 ± 40+ 600 ± 130? 110 ± 204 3,400 ± 460
1,500 ± 4804 1,600 ± 18044? 4,500 ± 55044? 5,200 ± 2,90044? 1,200 ± 3501 160 ± 204 14,000 ± 2,9004?
490 ± 30 500 ± 70 1,100 ± 1704 170 ± 20l 1,000 ± 460 90 ± 104 3,400 ± 650
720 ± 90t 1,300 ± 2601 3,800 ± 880tt 2,700 ± 1,400tt 840 ± 1901 210 ± 30 9,500 ± 1,600tt
1,300 ± 300 750 ± 170 2,000 ± 570 530 ± 1000 240 ± 604 180 ± 40 5,000 ± 1,0000
960 ± 1404ttt 1,200 310 3,200 ± 560tt 3,400 ± 1,000ttt 610 ± 1401 200 ± 30tt 9,600 ± 1,000ttt
5 mo
mg
12 mo 5 mo 12 mo
mg
77.6 ± 6.8 (4)` 88.0 ± 24.0 (3) 17.8 ± 0.4 (4) 12.0 ± 3.8 (3)
144 ± 16 (3)4 132 ± 23 (6) 27.4 ± 1.6 (3)4 21.9 ± 3.1 (6)
85.7 ± 4.7 (9) 80.0 ± 2.0 (2) 18 .5 ± 1.0 (9) 12 .2 ± 3.1 (2)
57.9 ± 8.1 (6) 45.3 ± 6.4 (5)i Nodes atrophic Nodes atrophic
195 ± 3 (3)44t 397 ± 151 (6)44tt 231 ± 34 (3)t 150 ± 43 (6)tt
53.2 ± 3.8 (8)444 43.1 ± 10.5 (3)i Nodes atrophic Nodes atrophic
122 ± 18 (6)t 272 ± 59 (5)t 100 ± 20 (6)tt 644 ± 160 (5)t
136 ± 31 (3) 170 ± 27 (8) 28.3 ± 2.8 (3)a4 96.1 ± 32 .6 (8)ott
164 ± 17 (8)ttt Dead 199 ± 39 (8)4ttt DeadCO
0
N
E
0
m
N
Days Post-Transfer
vironments, and therefore shows that the lpr/lpr and gld/gld
host environments are functionally distinguishable.
RecipientsofgldlgldBone Marrow Cells.
￿
Recipients ofgld/gld
bone marrow did not develop an lprllpr - + /+ -like lym-
phoid wasting syndrome. In fact, significant lymphadenop-
athy and splenomegaly were observed ingld/gld - + /+ and
g1dlgld - gldlgld chimeras necropsied 5 or 12 mo post-transfer
(Table 3, groups 3a and 3c) . However, gld/gld -> lprllpr
chimeras (Table 3, group 3b) demonstrated far less lymphade-
nopathy than gldlgld - + /+ (or gldlgld -gldlgld) chimeras.
This effect was not due to an inability ofthe lprllpr host en-
vironment to support lymphoproliferation, since lprllpr -"
lprllpr chimeras (Table 3, group 2b) demonstrated spleno-
megaly and lymphadenopathy comparablewith those observed
ing1d/gld - + /+ (Table 3, group 3a) and gld/gld -gld/gld
(Table 3, group 3c) chimeras. Thus, the slow rate ofdevelop-
ment of lymphadenopathy in gld/gld - lprllpr chimeras ap-
pears to be due to an abnormal interaction occurring between
gld/gld marrow-derived cells and the lprllpr host environment.
Ig levels in gld/gld -" lpr/lpr chimeras (Table 4, group 3b)
were not significantly elevated at 5 mo post-transfer, and were
in fact much lower than those in gld/gld --> gld/gld (Table
4, group 3c) orgld/gld -" + /+ (Table 4, group 3a) chimeras
at this time. This finding was supported by the kinetic anal-
ysis ofIgG2b levels (Fig. 1), which increased steadily ingld/gld
-> gld/gld and gld/gld - + /+ chimeras, but much more
slowly and with a later time of onset in gld/gld - lprllpr
chimeras. Even after 1 yr, IgG2b levels in gld/gld - lprllpr
chimeras were ti 10 times lowerthan levels in gld/gld - + /+
or gld/gld --" gld/gld chimeras.
These findings with gld/gld bone marrow cells confirm the
existence of a functional difference between the lpr/lpr and
gld/gld host environments.
Recipients of + / + Bone Marrow Cells.
￿
Throughout these
studies, + /+ -> lprllpr chimeras demonstrated slight abnor-
malities when compared with + /+ -" + /+ or + /+ -"
gldlgld chimeras. Whereas organweights from + /+ -> gldlgld
chimeras were indistinguishable from those in + /+ - + /+
chimeras, + /+ - lprllpr chimeras developed a small degree
of lymphadenopathy (Table 3). Serum IgG2b levels in + /+
1371
￿
Allen et al,
94/94-->+/+ t
- r/lp- rr-->lp- rr/)p - r tttt
94/94-->94/9i-d
lpr/lpr-->g /94 +7+-->lpr .pr db
rlpr/lpr-->+/+ i
Figure 1.
￿
Kineticanalysis ofchangesinserumIgG2b
levels ofbone marrow chimeras constructed using all
nine possible congenic C3H-+ /+ ,
-(pr/1
pr, and gld/gld
donor - host combinations. Each point represents the
mean of two to eight animals. Anow symbols refer
to statisticalcomparison ofserum IgG2b levels at 300
d post-transfer and were used as defined in Table 3.
Errorbars represent 1 SE above and/or below themean.
(*) The gld/gld-,-gld/gld group consistedofonly two
animals at 300 d, resulting in a low significance level
(0.061 by MannWhitney analysis when compared with
the + /+ -o- g1d/g1d group) despite the obvious eleva-
tion in IgG2b levels in this group.
lpr/lpr chimeras also tended to be depressed (Fig. 1), being
>1 SD below mean levels of + /+ - + /+ chimeras in 23/33
sera obtained at 100 or more days post-transfer, whereas only
3/18 + /+ --" gld/gld sera obtained at comparable times fell
in this category (assuming a normal distribution, it would
be expected that one in six sera would be >1 SD below the
mean). Thus, even + /+ bone marrow behaves differently
in the lprllpr vs. the gld/gld host environments.
Discussion
Although the lpr and gld mutations cause indistinguish-
able autoimmune syndromes in homozygous mice, they be-
havevery differently afterbone marrow transfer in two ways.
First, gld/gldbone marrow does not induce a lymphoid wasting
syndrome in irradiated congenic + /+ recipients analogous
to that induced by lprllpr bone marrow. Second, there are
fundamental differences in the behavior of all three marrow
types studied when transferred to lprllpr vs. gldlgld (or + /+ )
host environments. Thus, lpr/lpr bone marrow causes a lym-
phoid wasting syndrome in gld/gld (and + /+) recipients,
but a lymphoproliferative syndrome in lprllpr recipients;gldlgld
bone marrow causes a lymphoproliferative syndrome ingld/gld
(and + /+ ) recipients, but this syndrome is significantly
retarded in lprllpr recipients; and + /+ bone marrow com-
pletely normalizesgld/gld (and + /+ ) recipients, but fails to
do so in lpr/lpr recipients. Two possible explanations for these
different behaviors are: (a) the lpr mutation may be linked
to (or give rise to) a histocompatibility antigen that causes
the effects noted above, whereas the gld mutation is not as-
sociated with any antigenic alteration; or (b) the lpr and gld
mutations may be functionally different with respect both
to donor bone marrow and host environment effects.
An antigenic basis for these differences is unlikely for sev-
eral reasons. First, the GVH-like reaction induced by lprllpr
bone marrow has several notable differences from a typical
antigen-induced GVH-syndrome. One such difference is that
the GVH-like reaction here is not initiated by mature T cells
present in the bone marrow inoculum (10-12). Second, al-though the reaction is T cell dependent, we have previously
demonstrated that either + /+ or lpr/1prT cells will mediate
it (12), suggesting that their role is not in recognition of
foreign antigen. Third, the increase in IgG1 levels that parallels
the early inflammatory response occurring in lpr/lpr - + /+
chimeras also occurs in lpr/lpr - lpr/1pr chimeras, and thus
cannot be caused by an antigenic disparity (12). The most
likely explanation of the results reported here is that there
is a functional difference between the effects of the lpr and
gld mutations that becomes apparent after bone marrow
transfer.
In additionto this putative functional difference, the results
reported here suggest that the 1pr and gld mutations are ex-
pressed by different cell lineages or developmental stages. Bone
marrow transfer allows splitting of the immune system into
two cellular compartments. One ofthese consists ofradiation-
sensitive, bone marrow-derived cells and is donor-derived in
the resultant chimera. The other compartment consists of
radiation-resistant stromal tissue and long-lived, bone
marrow-derived cells, both of which are host derived in the
resultant chimera. We will referto thesetwo cellular subsets
as the bone marrow compartment and the peripheral com-
partment, respectively. Construction ofthe chimeras described
here allowed us to compare the behavior of these two sepa-
rate compartments in lpr/lpr and gld/gld mice.
The bone marrow compartment oflpr/lpr mice is abnormal
in that it induces a GVH-like reaction in both + /+ andgld/gld
recipients. The lpr/lpr peripheral compartment is also abnormal
as it behaves unlike the + /+ and gld/gld peripheral com-
partments when reconstituted with any ofthe three marrow
types studied. These facts indicate that the molecule altered
by the 1pr mutation is expressed by cells in both the bone
marrow and the peripheral compartments. The gld mutation,
on the other hand, appears to affect only the bone marrow
compartment, since the gld/gld peripheral compartment be-
havedsimilarly to that of + /+ mice in all cases studied. Thus,
the molecule altered by the gld mutation is expressed by a
population of cells that is completely contained within the
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bone marrow compartment. This differential localization of
functional expression of the lpr and gld mutations suggests
that the molecules affected are expressed by different cells.
If the lpr- and gld-affected genes are expressed by different
cells, and cause functional differences on both the donor and
recipient sides ofbone marrow transfers, the question arises
of how the lpr and g1d mutations can give rise to near iden-
tical autoimmune syndromes. In view of the finding that lpr
and gld are expressed by different cell subsets, it seems un-
likely that the genes affected by these mutations are involved
in sequential steps of a single metabolic pathway of T cells,
as has been suggested previously (6). An alternate possibility
that may fit the present observations better is that lpr and
gld may be mutations in interacting molecules (e.g., a cytokine
and its receptor or two interacting cell surface molecules ex-
pressed by different cell populations) (Fig. 2). In such a model,
the phenotype of lpr/lpr and gld/gld homozygotes would be
identical, since whether the receptor or ligand is impaired,
the interaction between the two molecules would fail and
the end result would be the same.
Since the molecule altered by the lpr mutation is hypothe-
sized to be expressed by both the bone marrow compartment
and by the 'peripheral compartment, whereas the molecule
altered by the g1d mutation is thought to be expressed only
by the bone'marrow compartment, the differential expres-
sion of these molecules in the various chimeras studied in
this paper can be derived. As indicated inTable 5, the devel-
opment oflpr- or gld--like autoimmune syndromes character-
ized by lymphadenopathy and hypergammaglobulinemia is
associated with situations in which either the gld-associated
molecule is replaced by the mutant gld variant or the lpr-
associatedmolecule is entirely replaced by the mutant Iprvariant
(i.e., in both the bone marrow and peripheral compartments).
Partial expression ofthe lpr variant (i.e., in the bone marrow
compartment but not the peripheral compartment or vice
versa) would be expected to occur in some of the chimeras
constructed (1pr11pr -> + /+ , lpr/lpr - gld/gld, + /+ ->
lpr/lpr, and gld/gld --~ lpr/lpr), and may provide a basis for
Figure 2.
￿
Suggested model of the relationship be-
tween the lpr- and gld-associated molecules. A bone
marrow-derived cell (A) secretes a cytokine, or ex-
presses a cell surface molecule (Molecule 1), that in-
teracts with a surface molecule (cytokine receptor?)
(Molecule 2) expressed byboth bone marrow-derived
cells (B) and peripheral cells (either peripheral lym-
phoid tissueor long-lived, radiation-resistant, marrow-
derived cells) (C). The gld mutation results in loss of
function of Molecule 1. The lpr mutation results in
loss of function of Molecule 2. Loss of function of
either molecule prevents the same interaction from oc-
curring, and autoimmunity develops as a result of a
cascade ofevents initiatedby failure ofthisinteraction.Table 5.
￿
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explaining the novel biological consequences of these transfers
(Table 5, group D). This situation would not occur in any
of the other chimeras studied (Table 5, groups A-C).
Considering the model proposed above in which gld and
Ipr may represent mutations in a cytokine-receptor pair, the
aberrant effects associated with partial expression of the lpr
variant could be explained by hypothesizing that production
of this rytokine involves feedback regulation via its receptor.
Thus, when cells with nonfunctional cytokine receptors (i.e.,
cells expressing the lpr variant) are present, rytokine produc-
tion would be dysregulated, leading to higher than normal
levels ofrytokine. Partial expression of the functional cytokine
receptor would mean some cells would be present that can
respond to the rytokine while other cells present (those ex-
pressing the nonfunctional Ipr variant) may produce it in a
dysregulated manner. Thus, the aberrant effects observed in
the chimeras expected to have partial expression of the non-
functional (lpr) variant of the receptor could be due to the
response of a cell population bearing normal cytokine receptor
to high levels of the rytokine produced by a cell population
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Considering that gld is a mutation in a hypothetical molecule (Molecule 1) that is expressed only in the bone marrow compartment, while lpr is
a mutation in a second hypothetical molecule (Molecule 2) that is expressed in both the bone marrow and peripheral compartments (Fig. 2), the
expected expression of either the normal (i.e., wild-type) or mutant (gld in the case of Molecule 1; lpr in the case of Molecule 2) forms of each
molecule in the various chimeras studied is indicated.
The gld variant of Molecule 1 would be expressed in the bone marrow compartment only when donor marrow was of the gld/gld genotype.
t The lpr variant of Molecule 2 would be expressed in the bone marrow compartment only when donor marrow was of the lprllpr genotype.
5 The lpr variant of Molecule 2 would be expressed in the peripheral compartment only when the host was of the lprllpr genotype.
bearing nonfunctional (lpr) cytokine receptor. Specifically, the
GVH-like syndrome occurring in lprllpr--> + /+ and lprllpr
- gld/gld chimeras vs. the lymphoproliferative syndrome in
lprllpr homozygotes and lprllpr -+ lprllpr chimeras may re-
sult from the normal responses of peripheral + /+ or gld/gid
cells but not of peripheral lprllpr cells to the involved cytokine.
Similarly, the impaired responses of + /+ --" lprllpr and gld/gld
--" lprllpr chimeras compared with those of + /+ - + /+
andgldlgld --" + /+ chimeras may reflect the inability of lprllpr
peripheral cells to respond to the rytokine.
The novel effects observed in chimeras expected to have
partial expression of the lpr-associated gene product are per-
haps a clue to thenormal function(s) of this molecule. Partial
expression by peripheral tissue (in lprllpr - + /+ and lprllpr
gld/gld chimeras) causes the development of an early inflam-
matory response characterized by neutrophil influx into the
spleen and lymph nodes and a subsequentlymphoid wasting
syndrome. This suggests that the molecules altered by the
lpr and gld mutations may be involved in mediating inflam-
matory responses.
Chimera
Hypothetical
Molecule 1 (gld)
marrow"
expression of molecules
Molecule 2 (lpr)
Marrow# Peripherals Effects observed
A. Normal form of both molecules
Unmanipulated + / + Normal Normal Normal No abnormalities
+/+ -+ +/+ Normal Normal Normal No abnormalities
+ / + - gld/gld Normal Normal Normal No abnormalities
B. Altered (gld) form of Molecule 1
Homozygous gld/gld gld Normal Normal Lymphadenopathy/elevated Ig
gld/gld -- gld/gld gld Normal Normal Lymphadenopathy/elevated Ig
gld/gld -- + / + gld Normal Normal Lymphadenopathy/elevated Ig
C. Altered (lpr) form of Molecule 2
(complete expression)
Homozygous lpr/lpr Normal lpr lpr Lymphadenopathy/elevated Ig
lpr/lpr -- lprllpr Normal lpr lpr Lymphadenopathy/elevated Ig
D. Altered (Ipr) form of Molecule 2
(partial expression)
lprllpr -- + / + Normal Ipr Normal GVH-like syndrome
lpr/lpr - gld/g1d Normal lpr Normal GVH-like syndrome
+ / + - Ipr/Ipr Normal Normal lpr Decreased Ig levels
gld/gld -- lprllpr gld Normal lpr Impaired gld-like syndromeRecently, a new mutation at the lpr locus, lpr1g, has been
described (15). Unlike the original lpr allele, the lprcg allele
"complements" the gld mutation; i.e., lprlg/+ , gld/+ double
heterozygotes develop lymphadenopathy similar to what occurs
in lpr/lpr or gld/gld homozygous mice, whereas lpr/+, gld/+
double heterozygotes appear normal. Our model could ex-
plain this differenceby proposing that the lpr mutation results
in a nonfunctional, non-ligand-binding receptor, whereas the
lprcg mutation results in a nonfunctional receptor that
nevertheless binds ligand. In lpr1g/+ heterozygotes, the non-
functional receptor would compete for ligand with the func-
tional receptor, thus lowering the effective ligand concentra-
tion. In lprlg/+ , gld/+ double heterozygotes, the effective
ligand concentration would first be decreased as a result of
the presence of one dose of thegld allele as transcripts from
this allele would be ineffective. Additionally, the presence of
the lpr1g allele would further lower the effective ligand con-
centration as nonfunctional receptor would compete for avail-
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